Ticagrelor


( Last Updated : June 8, 2010)
Generic Name:
Ticagrelor
Project Status:
Cancelled
Therapeutic Area:
Acute Coronary Syndromes
Manufacturer:
AstraZeneca Canada Inc
Call for patient/clinician input open:
Brand Name:
Brilinta
Project Line:
Reimbursement Review
Project Number:
SR0203-000
Call for patient/clinician input closed:

Details


Submission Type:
Initial
Indications:
Acute Coronary Syndromes (ACS)